ClinicalTrials.gov
public full text
Public Domain
Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency
This was an open-label, repeat-dose, study of sebelipase alfa in infants with rapidly progressive lysosomal acid lipase deficiency (LAL-D). Eligible participants received once-weekly infusions of sebelipase alfa for up to 3 years.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis#1172395
- Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia#857116
- PUFA Supplementation in Premature Infants#1059878
- Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms#868170
- Prevalence of Clinical Vitamin A Deficiency and Associated Factors Among Children Aged 24-59 Months in Finote Selam Town, Ethiopia: A Community Based Cross-Sectional Study, 2022.#446306
Record · ID 889398
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive